Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Drug Profile

SY 005

Alternative Names: Annexin A5 based therapeutics - Lawson Health Research Institute/Yabao Pharmaceuticals; Dianexin based therapeutics - Lawson Health Research Institute/See more

Latest Information Update: 28 May 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lawson Health Research Institute; Yabao Pharmaceutical Group
  • Class Biological peptides; Calcium binding proteins; Eye disorder therapies; Recombinant fusion proteins
  • Mechanism of Action Phosphatidylserine receptor modulators; Phospholipase A2 inhibitors; Urokinase-type plasminogen activator stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Sepsis

Most Recent Events

  • 28 May 2022 No recent reports of development identified for phase-I development in Sepsis in China (IV, Injection)
  • 24 May 2021 Yabao Pharmaceuticals plans a phase II trial for Sepsis (In adults, In the elderly) (IV) in July 2021 (NCT04898322)
  • 10 Feb 2021 Lawson Health Research Institute, Ontario Ministry of Colleges and Universities and London Health Sciences Foundation plan the phase I AX-COVID trial for Sepsis and severe COVID-19 infections in Canada (IV, Infusion) (NCT04748757), in March 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days